LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE TREATED WITH RITUXIMAB

被引：0
|
作者：
Desinova, Oxana
Starovoytova, Mayya
Shayakhmetova, Rushana
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1091
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1188A / 1188A
页数：1
相关论文
共 50 条
  • [1] Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease in Brazil A Real-Life, Long-Term Follow-up Observational Study
    de Oliveira Martins, Lucas Victoria
    Oliveira, Sandra Maximiano
    Silvatti, Juliana
    de Amorim, Fernanda Godinho
    Tito, Cecilia V. Agapito
    Kayser, Cristiane
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E532 - E538
  • [2] Long-Term Follow-Up of Interstitial Pneumonia Associated with Systemic Sclerosis
    Jinta, T.
    So, C.
    Tomishima, Y.
    Ro, S.
    Manabu, M.
    Imai, R.
    Tsugitomi, R.
    Okafuji, K.
    Kitamura, A.
    Nishimura, N.
    Okada, M.
    Tamura, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [3] IDIOPATHIC INFLAMMATORY MYOPATHIES WITH INTERSTITIAL LUNG DISEASE TREATED WITH RITUXIMAB AND LONG-TERM FOLLOW-UP
    Khelkovskaya-Sergeeva, Anna
    Ananyeva, Lidia
    Koneva, Olga
    Garzanova, Liudmila
    Kulikovsky, Dmitry D.
    Desinova, Oxana
    Aristova, Maria
    [J]. CHEST, 2022, 162 (04) : 2252A - 2252A
  • [4] THE EFFECT OF RITUXIMAB ON LUNG FUNCTION AND SKIN SCORE IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE. LONG-TERM OBSERVATION
    Garzanova, Liudmila
    Ananyeva, Lidia P.
    Koneva, Olga
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Volkov, Alexander
    Glukhova, Svetlana
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1213 - 1214
  • [5] Systemic sclerosis-associated interstitial lung disease treated with tocilizumab
    Dauny, Vincent
    Borie, Raphael
    Forien, Marine
    Ghanem, Mada
    Palazzo, Elisabeth
    Jelin, Germain
    Dieude, Philippe
    Ottaviani, Sebastien
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 (06) : 999 - 1000
  • [6] A BENEFICIAL EFFECT OF LONG-TERM TREATMENT OF RITUXIMAB IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, Lidia
    Koneva, Olga
    Garzanova, Liudmila
    Starovoytova, Mayya
    Desinova, Oxana
    Ovsyannikova, Olga
    Shayakhmetova, Rushana
    [J]. CHEST, 2022, 162 (04) : 2178A - 2178A
  • [7] LONG-TERM FOLLOW-UP OF REFRACTORY SYSTEMIC VASCULITIS TREATED WITH RITUXIMAB
    Yazdani, Ramin
    Lanyon, Peter
    [J]. RHEUMATOLOGY, 2010, 49 : I123 - I123
  • [8] Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients
    Sari, Alper
    Guven, Denizcan
    Armagan, Berkan
    Erden, Abdulsamet
    Kalyoncu, Umut
    Karadag, Omer
    Bilgen, Sule Apras
    Ertenli, Ihsan
    Kiraz, Sedat
    Akdogan, Ali
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (08) : 411 - 415
  • [9] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [10] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
12345